Peng Cui

Title: Innovations of Inventor Peng Cui

Introduction

Peng Cui is a notable inventor based in Charlottesville, VA, who has made significant contributions to the field of pharmaceutical sciences. He holds a total of four patents, showcasing his innovative approach to enhancing insulin secretion and protecting pancreatic beta-cells.

Latest Patents

Among his latest patents, one focuses on "Substituted phthalazines for inducing insulin secretion and protecting beta-cells." This invention provides phthalazine analogs of Lisofylline (LSF) and outlines synthetic methods for their preparation. The compounds have structural formulas that include various alkyl, alkenyl, or alkynyl groups, which can be pharmaceutically acceptable salts. These analogs are designed to protect cell viability, particularly pancreatic beta-cells, and induce insulin secretion. Another patent involves "Lisofylline analogs and methods for use," which presents analogs of LSF that possess an active side chain moiety (5-R-hydroxyhexyl). These analogs are noted for their greater potency and oral bioavailability compared to LSF.

Career Highlights

Peng Cui is affiliated with the University of Virginia, where he continues to advance his research and innovations in the pharmaceutical field. His work has the potential to significantly impact diabetes treatment and management.

Collaborations

He collaborates with esteemed colleagues such as Timothy L. MacDonald and Jerry L. Nadler, contributing to a rich environment of research and innovation.

Conclusion

Peng Cui's contributions to the field of pharmaceutical sciences through his patents and collaborations highlight his role as a leading inventor in the area of insulin secretion and beta-cell protection. His work continues to pave the way for advancements in diabetes treatment.